{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:52:22Z","timestamp":1791247942138,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Supported by Fundamental Research Program of Shanxi Province","award":["202403021222382"],"award-info":[{"award-number":["202403021222382"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05651-6","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:41:42Z","timestamp":1784191302000},"page":"4083-4094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRAF4 promotes nasopharyngeal carcinoma progression by stabilizing SETDB1 to suppress mitochondrial apoptosis"],"prefix":"10.1007","volume":"481","author":[{"given":"Jing-Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Xue","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Xin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"5651_CR1","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA: a cancer journal for clinicians. 71:209\u2013249","DOI":"10.3322\/caac.21660"},{"key":"5651_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01928-2","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu H, Tang L, Li Y, Xie W, Zhang L, Tang H, Xiao T, Yang H, Gu W, Wang H, Chen P (2024) Nasopharyngeal carcinoma: current views on the tumor microenvironment\u2019s impact on drug resistance and clinical outcomes. Mol Cancer 23:20","journal-title":"Mol Cancer"},{"key":"5651_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, Migliaccio A (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52:192\u2013203","journal-title":"Exp Mol Med"},{"key":"5651_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature08268","volume":"461","author":"ZT Schafer","year":"2009","unstructured":"Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS (2009) Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461:109\u2013113","journal-title":"Nature"},{"key":"5651_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41417-018-0056-8","volume":"26","author":"H Nakamura","year":"2019","unstructured":"Nakamura H, Takada K, Arihara Y, Hayasaka N, Murase K, Iyama S, Kobune M, Miyanishi K, Kato J (2019) Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer. Cancer Gene Ther 26:313\u2013322","journal-title":"Cancer Gene Ther"},{"key":"5651_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1080\/13880209.2023.2220754","volume":"61","author":"L Liu","year":"2023","unstructured":"Liu L, Yu Z, Chen J, Liu B, Wu C, Li Y, Xu J, Li P (2023) Lucialdehyde B suppresses proliferation and induces mitochondria-dependent apoptosis in nasopharyngeal carcinoma CNE2 cells. Pharm Biol 61:918\u2013926","journal-title":"Pharm Biol"},{"key":"5651_CR7","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhao SR, Liu F, Sun XJ, Liu H (2017) Oridonin Induces Apoptosis in Human Nasopharyngeal Carcinoma Cells Involving ROS Generation, Folia biologica. 63:155\u2013163","DOI":"10.14712\/fb2017063040155"},{"key":"5651_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/toxres\/tfab087","volume":"10","author":"YJ Zhang","year":"2021","unstructured":"Zhang YJ, Mu ZL, Deng P, Liang YD, Wu LC, Yang LL, Zhou Z, Yu ZP (2021) 8-Formylophiopogonanone B induces ROS-mediated apoptosis in nasopharyngeal carcinoma CNE-1 cells. Toxicol Res 10:1052\u20131063","journal-title":"Toxicol Res"},{"key":"5651_CR9","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1158\/0008-5472.CAN-21-3882","volume":"82","author":"Y Li","year":"2022","unstructured":"Li Y, Wang T, Wan Q, Wang Q, Chen Z, Gao Y, Ye Y, Lin J, Zhao B, Wang H, Yang J, Zhao K, Lu N (2022) TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance. Cancer Res 82:3573\u20133587","journal-title":"Cancer Res"},{"key":"5651_CR10","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1172\/JCI96060","volume":"128","author":"R Singh","year":"2018","unstructured":"Singh R, Karri D, Shen H, Shao J, Dasgupta S, Huang S, Edwards DP, Ittmann MM, O\u2019Malley BW, Yi P (2018) TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis. J Clin Investig 128:3129\u20133143","journal-title":"J Clin Investig"},{"key":"5651_CR11","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1007\/s11064-023-03882-3","volume":"48","author":"Y Gu","year":"2023","unstructured":"Gu Y, Zhong K, Peng L, Ding W, Zeng X (2023) TRAF4 Silencing Induces Cell Apoptosis and Improves Retinoic Acid Sensitivity in Human Neuroblastoma. Neurochem Res 48:2116\u20132128","journal-title":"Neurochem Res"},{"key":"5651_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7150\/ijbs.87180","volume":"20","author":"J Liao","year":"2024","unstructured":"Liao J, Qing X, Li X, Gan Y, Wang R, Han S, Li W, Song W (2024) TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance. Int J Biol Sci 20:182\u2013199","journal-title":"Int J Biol Sci"},{"key":"5651_CR13","doi-asserted-by":"crossref","unstructured":"Gu H, Zhu S, Peng C, Wei Z, Shen Y, Yuan C, Yang H, Cui H, Yang L (2022) TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway. Int J Mol Sci, 23","DOI":"10.3390\/ijms231710161"},{"key":"5651_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3389\/fgene.2020.00997","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Chen X, Liu Y, Zhang P, Zheng Y, Zeng W (2020) The Histone Methyltransferase SETDB1 Modulates Survival of Spermatogonial Stem\/Progenitor Cells Through NADPH Oxidase. Front Genet 11:997","journal-title":"Front Genet"},{"key":"5651_CR15","first-page":"1017","volume":"40","author":"J Huang","year":"2018","unstructured":"Huang J, Huang W, Liu M, Zhu J, Jiang D, Xiong Y, Zhen Y, Yang D, Chen Z, Peng L, Yu Z (2018) Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma. Oncol Rep 40:1017\u20131025","journal-title":"Oncol Rep"},{"key":"5651_CR16","doi-asserted-by":"publisher","first-page":"100199","DOI":"10.1016\/j.mocell.2025.100199","volume":"48","author":"MJ Morgan","year":"2025","unstructured":"Morgan MJ, Kim YS (2025) RIPK3 in necroptosis and cancer. Mol Cells 48:100199","journal-title":"Mol Cells"},{"key":"5651_CR17","doi-asserted-by":"crossref","unstructured":"Chen L, Zhang Y, Lai SZ, Li WF, Hu WH, Sun R, Liu LZ, Zhang F, Peng H, Du XJ, Lin AH, Sun Y, Ma J (2019) 10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma, The oncologist. 24:e38\u2013e45","DOI":"10.1634\/theoncologist.2017-0577"},{"key":"5651_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4143\/crt.2021.101","volume":"54","author":"L Wang","year":"2022","unstructured":"Wang L, Miao J, Huang H, Chen B, Xiao X, Zhu M, Liang Y, Xiao W, Huang S, Peng Y, Deng X, Lv X, Xia W, Xiang Y, Guo X, Han F, Zhao C (2022) Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up. Cancer Res Treat 54:118\u2013129","journal-title":"Cancer Res Treat"},{"key":"5651_CR19","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1002\/cncr.30198","volume":"122","author":"JJ Pan","year":"2016","unstructured":"Pan JJ, Ng WT, Zong JF, Lee SW, Choi HC, Chan LL, Lin SJ, Guo QJ, Sze HC, Chen YB, Xiao YP, Kan WK, O\u2019Sullivan B, Xu W, Le QT, Glastonbury CM, Colevas AD, Weber RS, Lydiatt W, Shah JP, Lee AW (2016) Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122:3307\u20133315","journal-title":"Cancer"},{"key":"5651_CR20","doi-asserted-by":"publisher","first-page":"842072","DOI":"10.3389\/fonc.2022.842072","volume":"12","author":"X Ruan","year":"2022","unstructured":"Ruan X, Zhang R, Li R, Zhu H, Wang Z, Wang C, Cheng Z, Peng H (2022) The Research Progress in Physiological and Pathological Functions of TRAF4. Front Oncol 12:842072","journal-title":"Front Oncol"},{"key":"5651_CR21","first-page":"76","volume-title":"SRC-3\/TRAF4 facilitates ovarian cancer development by activating the PI3K\/AKT signaling pathway, Medical oncology","author":"Y Wang","year":"2023","unstructured":"Wang Y, Luo X, Wu N, Liao Q, Wang J (2023) SRC-3\/TRAF4 facilitates ovarian cancer development by activating the PI3K\/AKT signaling pathway, Medical oncology, vol 40. Northwood, London, England, p 76"},{"key":"5651_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1158\/0008-5472.CAN-20-2906","volume":"81","author":"D Strepkos","year":"2021","unstructured":"Strepkos D, Markouli M, Klonou A, Papavassiliou AG, Piperi C (2021) Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential. Cancer Res 81:525\u2013534","journal-title":"Cancer Res"},{"key":"5651_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41420-022-01204-0","volume":"8","author":"L Cao","year":"2022","unstructured":"Cao L, Liu X, Zheng B, Xing C, Liu J (2022) Role of K63-linked ubiquitination in cancer. Cell death discovery 8:410","journal-title":"Cell death discovery"},{"key":"5651_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12915-024-02048-z","volume":"22","author":"K Xia","year":"2024","unstructured":"Xia K, Hui Y, Zhang L, Qiu Q, Zhong J, Chen H, Liu X, Wang L, Chen Z (2024) SETDB1 targeting SESN2 regulates mitochondrial damage and oxidative stress in renal ischemia-reperfusion injury. BMC Biol 22:246","journal-title":"BMC Biol"},{"key":"5651_CR25","doi-asserted-by":"publisher","first-page":"e13648","DOI":"10.1111\/eci.13648","volume":"52","author":"T Islam","year":"2022","unstructured":"Islam T, Afonso MB, Rodrigues CMP (2022) The role of RIPK3 in liver mitochondria bioenergetics and function. Eur J Clin Invest 52:e13648","journal-title":"Eur J Clin Invest"},{"key":"5651_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molcel.2023.11.001","volume":"84","author":"F Hecht","year":"2024","unstructured":"Hecht F, Zocchi M, Alimohammadi F, Harris IS (2024) Regulation of antioxidants in cancer. Mol Cell 84:23\u201333","journal-title":"Mol Cell"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05651-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:03:16Z","timestamp":1791244996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05651-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5651"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05651-6","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}